Preclinical study explores approved drug for ovarian cancer
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian...
A study lead by the University of Barcelona opens new perspectives to better understand how the molecular mechanisms involved in...
The World Mitochondria Society (WMS) and the International Society of Microbiota (ISM) are proud to announce the First World Conference...
An analysis of pre-treatment tumor specimens from 105 patients with localized muscle-invasive bladder cancer found that the presence of a...
Asbestos, a group of naturally occurring fibrous minerals, has been historically used for its durability and resistance to heat. Despite...
In a healthy human body, tissue growth and development are coordinated by many different mechanisms. Within our bodies, these mechanisms...
Hepatic cell carcinoma (HCC), the fifth most prevalent malignancy worldwide and the fourth leading cause of cancer-related mortality, poses significant...
Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals’ risk of developing liver cancer. In a new...
MIAMI, FLORIDA (July 25, 2024) – Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy...
Cervical cancer ranks as the fourth most common malignancy among women worldwide, primarily originating in the lower part of the...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine